Long-Term Outcome of Percutaneous Ablation in Very Early-Stage Hepatocellular Carcinoma

Journal of Gastrointestinal Surgery

Volumn 15, Issue 12, 2011, Pages 2165-2171

  Kuang, Ming ^a   Xie, Xiao Yan ^a   Huang, Cheng ^b   Wang, Ye ^a   Lin, Man Xia ^a   Xu, Zuo Feng ^a   Liu, Guang Jian ^a   Lu, Ming De ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Early stage; Hepatocellular carcinoma; Percutaneous ablation

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; CANCER STAGING; CATHETER ABLATION; CHINA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MICROWAVE RADIATION; MIDDLE AGED; MORTALITY; PATHOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHINA; DISEASE-FREE SURVIVAL; ETHANOL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 81355146657     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1716-2     Document Type: Article

References (32)

1. El-Serag HB, and Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
2. Peto J. Cancer epidermiology in the last century and the next decades. Nature 2001; 411: 390-395.
3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127(5 suppl 1): S5-S16.
4. Pisani P, Parkin M, Bray F, Ferlay J. Estimates of the worldwide morality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
5. Bruix J and Sherman M. Management of Hepatocellular Carcinoma. Hepatology 2005; 42: 1208-1236.
6. Llovet JM, Fuster J, and Bruix J of the Barcelona-Cli{dotless}′nic Liver Cancer Group. The Barcelona Approach: Diagnosis, Staging, and Treatment of Hepatocellular Carcinoma. Liver Transpl 2004; 10: S115-S120.
7. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
8. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91: 1479-1486.
9. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-1360.
10. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-08.
11. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellulcar carcinoma. Ann Surg 2005; 242: 36-42.
12. Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006; 86: 801-805.
13. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellulcar carcinoma. Ann Surg 2006; 243: 321-328.
14. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellulcar carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127(Suppl): 159A-169A.
15. Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, et al. Percutaneous radiofrequency ablation for early-stage hepatocellulcar carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institute series. Eur Radiol 2007; 17: 684-692.
16. Lencioni R, Cioni D, Crocetti L, Franchini C, Della Pina C, Lera J, et al. Early-stage hepatocellular carcinoma in cirrhosis: long term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967.
17. Xu HX, Xie XY, Lu MD, Chen JW, YinXY, Xu ZF, et al. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 2004; 59: 53-61.
18. Hines-Peralta A, Liu ZJ, Horkan C, Solazzo S, Goldberg SN. Chemical tumor ablation with use of a novel multiple-tine infusion system in a canine sarcoma model. J Vasc Interv Radiol 2006; 17: 351-358.
19. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, et al. Hepatocellulcar carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-172.
20. Kuang M, Lu MD, Xie XY, Xu HX, Mo LQ, Liu GJ, et al. Liver cancer: Increased microwave delivery to ablation zone with cooled-shaft antenna: Experimental and clinical studies. Radiology 2007, 242: 914-924.
21. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: Therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464.
22. Livraghi T, Meloni F, Stasi MD, Rolle E, Solbiati L, Tinelli G, et al. Sustained complete response and complications rate after radiofrequency ablation of very early hepatocellulcar carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89.
23. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an eastern point of view. Liver Transpl 2004; 10: S3-S8.
24. Livraghi T. Role of Percutaneous ethanol injection in the treatment of hepatocellular Carcinoma. Dig Dis 2001; 19: 292-300.
25. Sasaki Y, Imaoka S, Ishiguro S, Nakano H, Kasugai H, Fujiita M, et al. Clinical features of small hepatocellular carcinoma as assessed by histologic grades. Surgery 1996; 119: 252-260.
26. Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, et al. Satellites lesions in patients with small hepatocellular carcinoma with reference to clinipathologic features. Cancer 22; 95: 1931-1937.
27. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal invasion and intrahepatic micrometastasis in small hepatocellulcar carcinoma by gross type. Hepatol Res 2003; 26: 142-147.
28. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-726.
29. Choi GH, Kim DH, Kang CM, et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol. 2008; 15: 618-629.
30. Yamamoto M, Takasaki K, Otsubo T, Katsugarawa H, Katagiri S, Yshitoshi K, et al. Favorable surgical outcomes in patients with early hepatocellulcar carcinoma. Ann Surg 2004; 239: 395-399.
31. Minagawa M. Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellulcar carcinoma assessment of the Japanese TNM and AJCC/UICC TNM system in a cohort of 13, 772 patients in Japan. Ann Surg 2007; 245: 909-922.
32. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.